GSE239844 crizotinib 6 v 9 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE239844_crizotinib_6_v_9_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE239844_crizotinib_6_v_9_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE239844_crizotinib_6_v_9_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE239844_crizotinib_6_v_9_human_up.

Results found

Linked to

 

Label

Description

 

Gene

cytochrome P450 family 2 subfamily B member 7, pseudogene

Gene

non-coding RNA activated by DNA damage

Gene

general transcription factor IIi pseudogene 4

Gene

CASTOR family member 3, pseudogene

Gene

cutA divalent cation tolerance like, pseudogene

Gene

MIR1915 host gene

Gene

TP53 target 1

Gene

HOXD antisense growth-associated long non-coding RNA

Gene

MAGI2 antisense RNA 3

Gene

PSMG3 antisense RNA 1

  • Gene

    cytochrome P450 family 2 subfamily B member 7, pseudogene


  • Gene

    non-coding RNA activated by DNA damage


  • Gene

    general transcription factor IIi pseudogene 4


  • Gene

    CASTOR family member 3, pseudogene


  • Gene

    cutA divalent cation tolerance like, pseudogene




  • Gene

    HOXD antisense growth-associated long non-coding RNA


  • Gene

    MAGI2 antisense RNA 3


  • Gene

    PSMG3 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.